[A comparative clinical study of modified IA "3+4" regimen and intermediate-dose cytarabine regimen in the consolidation treatment of low-risk acute myeloid leukemia].
Liu XH, Jia JS, Wang J, Gong LZ, Tang FF, Yu WJ, Zhu XL, Wang Y, Jiang Q, Chang YJ, Zhao XS, Ruan GR, Qin YZ, Huang XJ, Jiang H.
Liu XH, et al. Among authors: jiang q, jiang h.
Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):594-597. doi: 10.3760/cma.j.issn.0253-2727.2022.07.011.
Zhonghua Xue Ye Xue Za Zhi. 2022.
PMID: 36709138
Free PMC article.
Chinese.
No abstract available.